|
N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]-4-(1,3-oxazol-5-yl)benzamide |
|
Yersinia |
TTSS (Type III secretion system) |
Preclinical (in vivo) |
Garrity-Ryan LK, et al. 2010. Infect Immun |
|
6-(3H-benzimidazol-5-yl)-3-pyridin-4-yl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole |
Depiction based on curated SMILES
N
N
N
N
HN
S
N
N
|
Staphylococcus |
Others |
Preclinical (in vivo) |
Zhang J, et al. 2014. Proc Natl Acad Sci U S A |
|
(5R,6R)-5,6-bis[(4-benzyltriazol-1-yl)methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
Depiction based on curated SMILES
N
H
N
N
N
N
N
H
N
H
N
H
2
N
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-butyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
N
N
N
H
2
N
N
H
N
N
H
3
C
N
H
3
C
H
H
N
|
Acinetobacter |
Biofilm |
Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem |
|
5beta,6alpha-Bis(4-heptyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
H
3
C
N
N
N
HN
H
2
N
N
N
N
N
H
3
C
H
H
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-hexyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
H
3
C
N
N
N
N
H
H
2
N
N
N
N
N
H
3
C
H
H
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
5beta,6alpha-Bis(4-pentyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine |
Depiction based on curated SMILES
N
N
H
3
C
N
HN
H
2
N
N
N
N
N
H
3
C
H
H
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
(5R,6R)-5,6-bis[(4-tert-butyltriazol-1-yl)methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
Depiction based on curated SMILES
N
N
N
H
2
N
HN
N
N
H
3
C
CH
3
H
3
C
N
CH
3
H
H
N
CH
3
H
3
C
|
Acinetobacter Staphylococcus |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
(5R,6R)-5,6-bis[[4-(2-phenylethyl)triazol-1-yl]methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
Depiction based on curated SMILES
N
H
N
N
N
N
NH
N
H
N
NH
2
|
Acinetobacter Pseudomonas Staphylococcus |
Biofilm Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
(5R,6R)-5,6-bis[[4-(3-methylbutyl)triazol-1-yl]methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine |
Depiction based on curated SMILES
N
N
H
3
C
CH
3
N
N
H
H
2
N
N
N
N
CH
3
N
H
3
C
H
H
|
Acinetobacter Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Huigens RW 3rd, et al. 2009. Org Biomol Chem
|
|
| | |